Pulmonary arterial enlargement predicts cardiopulmonary complications after pulmonary resection for lung cancer: a retrospective cohort study by unknown
RESEARCH ARTICLE Open Access
Pulmonary arterial enlargement predicts
cardiopulmonary complications after
pulmonary resection for lung cancer: a
retrospective cohort study
Keisuke Asakura1*, Shota Mitsuboshi2, Makoto Tsuji2, Hiroyuki Sakamaki1, Sotaro Otake1, Shinsaku Matsuda1,
Kaoru Kaseda2 and Kenichi Watanabe2
Abstract
Background: The finding of pulmonary arterial enlargement on computed tomography has been reported to be
associated with pulmonary hypertension. On the other hand, pulmonary hypertension is a known risk factor for
thoracic surgery. We investigated whether pulmonary arterial enlargement predicts cardiopulmonary complications
following pulmonary resection for lung cancer.
Methods: We reviewed 237 consecutive patients who underwent pulmonary resection for lung cancer.
Preoperative patient characteristics (sex, age, Brinkman index, cardiopulmonary comorbidities, cardiothoracic ratio,
pulmonary function, and pulmonary arterial enlargement) and surgical data (surgical procedure, pathological stage,
postoperative complications, mortality, and length of postoperative hospital stay) were analyzed. In order to
evaluate preoperative pulmonary arterial enlargement, we measured the diameter of the main pulmonary artery at
its bifurcation and that of the ascending aorta at its widest point using chest computed tomography and
calculated the ratio of the former diameter to the latter.
Results: In all, 16 patients developed postoperative cardiopulmonary complications and 221 did not. One patient
died from postoperative pneumonia. The mean age of patients who developed postoperative cardiopulmonary
complications was significantly higher than that of those who did not (78 ± 5 years vs 69 ± 9 years, P = 0.0001).
The pulmonary artery-to-ascending-aorta ratio was significantly higher in patients who developed postoperative
complications than in those who did not (0.94 ± 0.15 vs. 0.81 ± 0.11, P = 0.03). Other preoperative patient
characteristics and surgical data did not differ significantly between the groups. On multivariate analysis, pulmonary
artery-to-ascending-aorta ratio (0.1-point increase; odds ratio 2.3, 95 % confidence interval 1.5–3.5; P = 0.0002) and
age (1-year increase; odds ratio 1.2, 95 % confidence interval 1.1–1.3; P = 0.03) were found to be independent
predictors of postoperative cardiopulmonary complications.
Conclusions: A finding of pulmonary arterial enlargement on computed tomography is a potential predictor of
postoperative cardiopulmonary complications after lung cancer surgery.
Keywords: Lung cancer, Pulmonary resection, Pulmonary artery, Computed tomography, Pulmonary arterial
hypertension
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Background
Surgery is the standard therapeutic option in patients
with early-stage lung cancer. Despite advances in surgi-
cal techniques and perioperative care, postoperative
complication rates remain as high as 23–41 % [1–5]. To
improve the safety of surgical treatment for lung cancer,
it is important to identify which candidates are at high
risk of postoperative complications.
Pulmonary hypertension has been shown to be a pre-
dictor of postoperative cardiopulmonary complication
(PCC) and mortality after surgery [6–8]. Standard methods
for measuring the pulmonary arterial pressure include
Doppler echocardiography and cardiac catheterization.
However, performing these examinations is not practical in
all surgical candidates for reasons of invasiveness and cost.
It has been reported that the results of computed tomo-
graphic examination for pulmonary arterial enlargement
correlate with those of invasive or echocardiographic
measurements of pulmonary arterial pressure [9–11].
In the present study, the relationship between a finding
of pulmonary arterial enlargement on computed tom-
ography and PCCs following pulmonary resection was
retrospectively investigated to clarify the value of pul-
monary arterial enlargement as a predictor of PCCs in
lung cancer patients.
Methods
Between October 2008 and May 2013, 241 consecutive
patients with primary lung cancer underwent pulmonary
resection at Sagamihara Kyodo Hospital, a 400-bed
acute-care hospital. For this study, records of 237 of
these patients were reviewed retrospectively, with four
patients who underwent pneumonectomy being ex-
cluded. The Sagamihara Kyodo Hospital Ethical Com-
mittee approved the study. In accordance with the
Ethical Guidelines for Clinical Studies published by the
Japanese Ministry of Health, Labour and Welfare, the
Ethical Committee waived the need for individual pa-
tients to provide consent because of the retrospective
nature of the study, because consent could not be ob-
tained from all of the patients, and because individual
patients were not identified in the study.
Preoperatively, all patients underwent computed tomog-
raphy of the body, magnetic resonance imaging of the
brain, 18 F-fluoro-2-deoxyglucose positron emission tom-
ography, electrocardiography, and spirometric pulmonary
function tests. The spirometric pulmonary function tests
included tests of forced expiratory volume in 1 s (FEV1)
and diffusing capacity of the lung for carbon monoxide
(DLCO). Postoperative FEV1 and DLCO (ppoFEV1 and
ppoDLCO) were calculated based on the number of
segments to be removed. Data collected preoperatively
included the patients’ sex, age, Brinkman index, and
cardiopulmonary comorbidities. At our institution, the
eligibility criteria for pulmonary resection are a pre-
dicted ppoFEV1 and ppoDLCO >40 % of the average
values in normal individuals (i.e. %ppoFEV1 and
%ppoDLCO >40). Standard pulmonary resection was
performed using video-assisted thoracic surgery with
access via two skin incisions: an 8-cm incision used for
manipulation and a 1.5-cm incision in which the utility
port was placed to allow access for the thoracoscope,
staplers, and other instruments.
Examination for pulmonary arterial enlargement
Axial computed tomography was used to examine the
pulmonary artery for enlargement. Measurements were
performed by a physician (KA, MT, or SM) who did not
know the patient’s postoperative course. In accordance
with previous publications [12, 11, 9, 10], we measured
the diameter of the main pulmonary artery at the level
of its bifurcation and that of the ascending aorta at its
widest point, using the same image for both. The
measuring point of the main pulmonary artery is at the
rises of bilateral pulmonary arteries. The rises of the
main pulmonary arteries are obvious on axial com-
puted tomography in most patients, because the angles
of outline of pulmonary arteries change sharply at the
points (Fig. 1). Then, we calculated the ratio between
the diameters (pulmonary artery-to-ascending-aorta
ratio: PA/A ratio) as the index of pulmonary arterial
enlargement. We also calculated PA/A ratios on com-
puted tomography 3 months after surgery to assess
postoperative changes.
Postoperative cardiopulmonary complications
PCCs of lung resection may include one or more of the
following: (1) pneumonia, defined as the appearance of
pulmonary infiltrate on radiography, combined with fever
and leukocytosis; (2) acute respiratory distress syndrome;
(3) respiratory insufficiency requiring tracheostomy; (4)
respiratory failure requiring mechanical ventilation; (5)
atelectasis requiring bronchoscopic intervention; (6)
hypoxaemia requiring home oxygen therapy; (7) ar-
rhythmias requiring medication; (8) coronary artery
diseases (angina pectoris and myocardial infarction); (9)
acute heart failure requiring medication [13, 14]. Compli-
cations related to surgical technique, such as prolonged
air leaks, bronchopleural fistulas and chylothorax, were
not examined in this study.
Statistical analyses
Patients were divided into those who developed PCCs
and those who developed none, and differences in pa-
tient characteristics between the two groups were tested
using Fisher’s exact test or the Mann–Whitney U-test.
The cut-off PA/A ratio most likely to predict the occur-
rence of PCCs was determined by the receiver operating
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characteristic (ROC) curve. Among patients who devel-
oped PCCs, the incidence of each PCC was compared
between those with PA/A ratios above the cut-off value
and those with PA/A ratios under it, and differences in
PCCs between the two groups were tested using Fisher’s
exact test or the Mann–Whitney U test. Factors appear-
ing significant on these univariate analyses were further
analyzed with multivariate logistic regression to deter-
mine if any were independent predictors of the occur-
rence of PCCs. All tests were two-sided and used a 5 %
significance level. All data were analyzed using SPSS
software (SPSS Statistics 20, IBM, Armonk, NY, USA).
Results
Patient characteristics, surgical data, and postoperative
cardiopulmonary complications
Preoperative patient characteristics and surgical data are
summarized in Table 1. Of 237 patients who underwent
pulmonary resection for lung cancer, 16 patients
developed PCCs and 221 did not. Postoperative compli-
cations related to surgical procedure (prolonged air leak-
age in 24 patients and chylothorax in 2 patients) were
excluded from the analysis. The mean age of the patients
in the PCC group was significantly higher than that of
the patients in the non-PCC group (78 ± 5 years vs 69 ±
9 years, P = 0.0001). PA/A ratio was significantly higher
in the PCC group than in the non-PCC group (0.94 ±
0.15 vs 0.81 ± 0.11, P = 0.001). Other preoperative patient
characteristics, including sex, cardiothoracic ratio, car-
diopulmonary comorbidities, Brinkman index, FEV1 as a
percentage of the average value in normal individuals
(%FEV1), ratio of FEV1 to forced vital capacity (FEV1/
FVC), DLCO as a percentage of the average value in
normal individuals (%DLCO), predicted %ppoFEV1, and
predicted %ppoDLCO, did not differ significantly between
the two groups. Regarding the surgical procedures, bilo-
bectomy was performed in 3 patients, lobectomy in 182
(including 5 bronchovascular reconstructions and 3 resec-
tions of involved neighbouring structures), segmentectomy
in 42, and wedge resection in 10. The proportions of
Fig. 1 Measurement of the diameters of the pulmonary artery and
aorta. Axial chest computed tomographic image at the level of the
bifurcation of the main pulmonary artery. Measurements of the
diameter of the main pulmonary artery (PA) and that of the aorta
(A) at the level of the bifurcation were used to calculate the PA/A
ratio. Short arrows show the rises of the bilateral pulmonary arteries.
It is the measuring point of the diameter of PA
Table 1 Preoperative patient characteristics and surgical data
Characteristics Total No PCCs PCCs
(n = 237) (n = 221) (n = 16) P value
Age, years 70 ± 9 69 ± 9 78 ± 5 0.0001
Male, n (%) 160 (68) 148 (67) 12 (75) 0.6
Cardiopulmonary
comorbidity, n (%)
138 (58) 125 (57) 13 (81) 0.07
Cardiothoracic ratio 0.47 ± 0.05 0.47 ± 0.05 0.48 ± 0.08 0.7
Brinkman index 632 ± 627 620 ± 603 801 ± 903 0.6
%FEV1 108 ± 24 109 ± 23 100 ± 33 0.2
FEV1/FVC 71 ± 11 71 ± 10 68 ± 17 0.7
%DLCO 105 ± 31 105 ± 31 103 ± 31 0.8
%ppoFEV1 88 ± 21 87 ± 21 84 ± 29 0.4
%ppoDLCO 85 ± 26 85 ± 26 86 ± 27 0.9
PA/A ratio 0.82 ± 0.12 0.81 ± 0.11 0.90 ± 0.15 0.03
Surgical procedure, n (%) 1
Lobectomy or
bilobectomy
185 (78) 172 (78) 13 (81)
Segmentectomy or
wedge resection
52 (22) 49 (22) 3 (19)
Pathological stage, n (%) 0.4
Stage I 174 (73) 164 (74) 10 (63)
Stage II or III 63 (27) 57 (26) 6 (38)
All values are mean ± SD, unless otherwise indicated
VC vital capacity, FEV1 forced expiratory volume in 1 s, FVC forced vital
capacity, DLCO diffusing capacity of the lung for carbon monoxide,
ppoFEV1 predicted postoperative forced expiratory volume in 1 s, ppoDLCO
predicted postoperative diffusing capacity of the lung for carbon
monoxide, PA/A ratio pulmonary-artery-to-aorta ratio, POCs
postoperative complications
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patients who underwent lobectomies and other more ex-
tensive procedures did not differ significantly between the
PCC group and the non-PCC group (P = 1). The patho-
logical stage of the disease did not differ significantly be-
tween the two groups (P = 0.4).
Pulmonary arterial enlargement as a predictor of
postoperative cardiopulmonary complications
Figure 2 shows the area under the ROC curve (AUC), a
measure of discriminant or predictive power, to be 0.75
for PA/A ratio. The ratio showed the best combination
of sensitivity and specificity for prediction of PCCs at
values >1.0 (44 % sensitivity and 96 % specificity).
Incidence of particular postoperative cardiopulmonary
complications and significance of pulmonary arterial
enlargement
Table 2 shows the incidence of particular PCCs. Of the
237 patients in the study sample, 16 developed PCCs for a
morbidity rate of 6.8 %. Thirteen patients developed one
PCC, and 3 developed two PCCs. Atrial fibrillation
occurred in 7 patients, pneumonia in 5, atelectasis in 5,
hypoxemia requiring home oxygen therapy in 3, and acute
heart failure in 1. The overall incidence of PCCs was sig-
nificantly higher in patients with a PA/A ratio >1.0 than in
those with a PA/A ratio ≤1.0 (35 % vs 4 %, P = 0.0001).
The incidences of hypoxemia requiring home oxygen
therapy was significantly higher in patients with a PA/A
ratio >1.0 than in those with a PA/A ratio ≤1.0 (10 % vs
1 %, P = 0.02). The incidences of other particular PCCs
did not differ significantly between the two groups.
One patient with a PA/A ratio ≤1.0 died from pneumonia
on postoperative day 129 for an in-hospital mortality rate
of 0.4 % (1/241); obviously, the mortality rate did not differ
significantly between the two groups (P = 1).
Multivariate analysis
Age (P = 0.0001) and PA/A ratio (P = 0.03) were sig-
nificantly different between the PCC and the non-PCC
groups on univariate analysis. And cardiopulmonary
comorbidities (P = 0.07) tended to be more frequent in
the PCC group than in the non-PCC group on univari-
ate analysis. These factors were accordingly selected
for multivariate logistic regression analysis that identi-
fied PA/A ratio (0.1-point increase; odds ratio 2.3,
95 % confidence interval 1.5–3.5; P = 0.0002) and age
(1-year increase; odds ratio 1.2, 95 % confidence inter-
val 1.1–1.3; P = 0.003) as independent predictors of
PCCs (Table 3).
Fig. 2 Receiver operating characteristic curves for PA/A ratio in the
prediction of postoperative complications. The area under the
receiver operating characteristic curve (AUC), a measure of
discriminant or predictive power, was 0.75 for the ratio of the
pulmonary artery diameter to the aorta diameter. The ratio
showed the best combination of sensitivity and specificity for
prediction of postoperative complications at values >1.0 (44 %
sensitivity and 96 % specificity)







(n = 237) (n =217) (n = 20)
Any complication 16 (7) 9 (4) 7 (35) 0.0001
Atrial fibrillation 7 (3) 5 (2) 2 (10) 0.11
Pneumonia 5 (2) 3 (1) 2 (10) 0.06
Atelectasis 5 (2) 3 (1) 2 (10) 0.06
Hypoxaemia 3 (1) 1 (1) 2 (10) 0.02
Acute heart failure 1 (0.4) 0 (0) 1 (0.5) 0.08
30-day mortality 0 (0) 0 (0) (0) 1.0
In-hospital mortality 1 (0.4) 1 (0.4) 0 (0) 1.0
All values are n (%)
PCC postoperative cardiopulmonary complication, PA/A ratio
pulmonary-artery-to-aorta ratio
Table 3 Multivariate analysis of patient characteristics possibly
contributing to postoperative cardiopulmonary complications
Variable Category Odds ratio 95 % CI P value
PA/A ratio Lowest REF 1.5–3.5 0.0002
0.1-point increase 2.3




- REF 0.7–11.6 0.2
+ 2.5
CI confidence interval, PA/A ratio pulmonary-artery-to-aorta ratio, REF
reference parameter
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Preoperative and postoperative pulmonary artery size
Preoperative and postoperative PA/A ratios are shown in
Fig. 3. The postoperative PA/A ratio was significantly
higher (median: 0.85; 25th percentile: 0.78; 75th percent-
ile: 0.94) than the preoperative PA/A ratio (median: 0.81;
25th percentile: 0.74, 75th percentile: 0.89) (P < 0.0001).
Discussion
In this study, a finding of pulmonary arterial enlarge-
ment on computed tomography was associated with the
occurrence of PCCs following lung resection for cancer.
Of 237 patients who underwent such surgery, 16 devel-
oped PCCs for a morbidity rate of 6.8 %. The incidence
of PCCs was significantly higher in patients with PA/A
ratios >1.0 than in those with PA/A ratios ≤1.0. Multi-
variate logistic regression analysis showed that age and
PA/A ratio were independent predictors of PCCs.
The present study is the first to show the relationship
between pulmonary arterial enlargement on computed
tomography and the occurrence of PCCs following lung
resection for cancer. It is well known that pulmonary ar-
terial hypertension is associated with various diseases,
including left-sided heart disease, chronic obstructive
pulmonary disease, interstitial pulmonary disorders, and
pulmonary vascular disorders [15, 11, 16]. Moreover,
several studies indicate that preoperative pulmonary
hypertension may be a predictor of PCCs [7, 6, 8]. As we
did not routinely perform Doppler echocardiography, we
could not analyze the relationship between PA/A ratio
and pulmonary arterial pressure in our patients. How-
ever, several previous studies have demonstrated that
measurements of pulmonary arterial enlargement based
on computed tomography correlate with invasive or
echocardiographic measurements of pulmonary arterial
pressure [9–11]. Iyer et al. reported that a PA/A ratio >1.0
was 73 % sensitive and 84 % specific in identifying patients
with mean pulmonary arterial pressure >25 mmHg [11].
This suggests that the high incidence of PCCs in patients
with PA/A ratios >1.0 in the present study was caused,
at least in part, by pulmonary arterial hypertension.
Why is pulmonary hypertension in lung resection pa-
tients associated with PCCs? One hypothesis is that
pulmonary resection causes the loss of the pulmonary
artery bed, which elevates pulmonary arterial pressure
and may result in right ventricular dysfunction, particu-
larly in patients who already had pulmonary hyperten-
sion preoperatively [17]. Indeed, the current study
found PA/A ratios 3 months after surgery to be signifi-
cantly higher than those before surgery.
Although FEV1 [18, 2] and DLCO [3, 2] have previously
been reported to be strongly predictive of PCCs, they were
not significant predictors of PCCs in our study, possibly
because we excluded patients with very poor pulmonary
function from surgery. In fact, the predicted postoperative
pulmonary functions in our patients were very good, with
a mean predicted %ppoFEV1 of 87 % ± 22 % and a mean
predicted %ppoDLCO of 85 % ± 26 %.
The calculation of PA/A ratio based on computed
tomography is a well-established method for detecting
pulmonary hypertension [12, 11, 16, 9, 10]. Measuring
the diameter of main pulmonary artery at the rises of bi-
lateral pulmonary arteries is considered as a reprodu-
cible method. Iyer et al. reported the Cohen kappa of
0.82 (95 % CI, 0.68-0.97) for interobserver agreement in
the PA/A ratio based on computed tomography. A
Cohen’s Kappa above 0.8 is regarded as almost perfect
agreement. Additionally, the method involves no add-
itional cost and is non-invasive, as all candidates for lung
Fig. 3 A box-plot showing preoprerative and postoperative PA/A ratio. A box-plot shows the ratio between the diameters of the pulmonary
artery and aorta (PA/A ratio) preoperatively and 3 months after surgery. The postoperative PA/A ratio was significantly higher than the
preoperative ratio (P < 0.0001)
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resection undergo chest computed tomography pre-
operatively. Furthermore, the calculation can be com-
pleted in approximately 30 s. Given these advantages,
PA/A ratio is recommended for use in the assessment of
candidates for pulmonary resection.
This study had several limitations. Firstly, this study was
limited by its retrospective design. Secondly, the number
of patients involved in the study was small (n = 241). The
sample was of similar size to samples in several recent re-
ports from other organizations investigating predictive fac-
tors for PCCs following surgery for lung cancer [14, 5, 19].
However the morbidity of PCCs was very low (6.7 %,
n = 16) in the present study, so the number of patients
might be inadequate to evaluate the relationship be-
tween and PA/A ratio and each particular PCCs.
Thirdly, we could not analyze the relationship between
PA/A ratio and pulmonary arterial pressure, as we did
not routinely perform Doppler echocardiography.
Fourthly, cardiopulmonary exercise testing is currently
considered the gold standard of risk assessment for
lung resection candidates [20]; however, few of the pa-
tients in our sample underwent such testing. To further
clarify the clinical significance of PA/A ratio in pulmonary
resection candidates, large-scale prospective studies inves-
tigating its relationships with pulmonary arterial pressure
and cardiopulmonary exercise testing are needed.
Conclusions
A finding of pulmonary arterial enlargement on computed
tomography (PA/A ratio >1.0) is an independent predictor
of PCCs following pulmonary resection for lung cancer in
this particular study. Further investigation on PA/A ratio
in a large-scale prospective study is needed.
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